Olmutinib
CAS: 1353550-13-6
Ref. TM-T6918
| 2mg | 39.00 € | ||
| 5mg | 56.00 € | ||
| 10mg | 87.00 € | ||
| 25mg | 134.00 € | ||
| 50mg | 176.00 € | ||
| 100mg | 276.00 € | ||
| 200mg | 454.00 € | ||
| 1mL*10mM (DMSO) | 59.00 € |
Estimated delivery in United States, on Friday 29 Nov 2024
Product Information
Name:
Olmutinib
Synonyms:
- HM61713, BI 1482694
- HM61713
- BI 1482694
- N-[3-[[2-[[4-(4-Methyl-1-piperazinyl)phenyl]amino]thieno[3,2-d]pyrimidin-4-yl]oxy]phenyl]-2-propenamide
- 2-Propenamide, N-[3-[[2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]thieno[3,2-d]pyrimidin-4-yl]oxy]phenyl]-
- HM 61713
Description:
Olmutinib is an oral mutant-specific EGFR inhibitor for cancer treatment with potential lower toxicity.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
486.59
Formula:
C26H26N6O2S
Purity:
99.27%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T6918 Olmutinib
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
